NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine -

Categories: Cardiovascular disease

7 9/26/2018

STAT’s cheerleading coverage of prescription fish oil capsule lacks crucial context


Reuters Health lays out pros and cons of high resolution screening for heart patients; skimps on study limitations


Medical Daily story on Mediterranean diet study mostly echoes news release


NBC story built around one patient’s amazing stroke recovery; skimps on data suggesting result is unusual

5 4/14/2016

Solid effort by NBC on saturated fat study, though story lacked hard numbers on findings


Newer blood pressure meds “as good as old ones” — but at doing what exactly?


A gloss over costs in coverage of competing blood pressure meds — but also some strengths


“Wine can help” those with type 2 diabetes, says LA Times, but benefits aren’t quantified (and are actually quite small)

3 10/8/2015

Optimal balance of competing views on value of CT heart scans


Texting your way to heart health? NPR thoroughly examines the evidence